Communicating with patients about harms and risks.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.Drug safety · 2023
   Review
2. Avacopan improves patient perspective on steroid-related toxicity effects in a case with ANCA-associated vasculitis.Rheumatology advances in practice · 2023
   Article
3. Perceptions of opioid use and impact on quality of life in patients with musculoskeletal conditions within online health community forums.Rheumatology advances in practice · 2021
   Article
4. How Do Glucocorticoids Used in Rheumatic Disease Affect Body Weight? A Narrative Review of the Evidence.Arthritis care & research · 2020
   Review
5. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?BMC pregnancy and childbirth · 2018
   Review
6. Frequent discussion of insomnia and weight gain with glucocorticoid therapy: An analysis of Twitter posts.NPJ digital medicine · 2018
   Article
7. Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community.BMJ open · 2017
   Article
8. A plea for a more epidemiological and patient-oriented pharmacovigilance.European journal of clinical pharmacology · 2012
   Review
9. Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.PloS one · 2012
   Article
10. Bisphosphonates and esophageal cancer--a pathway through the confusion.Nature reviews. Rheumatology · 2011
    Review
11. Pharmacovigilance and the null hypothesis: do we do much for public health?Drug safety · 2011
    Article
12. Tamoxifen and the singing voice.PLoS medicine · 2005
    Article
13. Medical decision making: the family-doctor-patient triad.PLoS medicine · 2005
    Article
14. A person-centred approach to communicating risk.PLoS medicine · 2005
    Article

Corrections and comments

• Commented on by
  Medical decision making: the family-doctor-patient triad.2005
• Commented on by
  Tamoxifen and the singing voice.2005

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as